This systematic review evaluated proton-pump inhibitors (PPIs) for stress ulcer prophylaxis in critically ill patients. Twelve trials with 9,533 patients were included. PPIs reduced clinically significant upper gastrointestinal bleeding (RR, 0.51; 95% CI, 0.34 to 0.76; high certainty). PPIs showed little to no effect on mortality (RR, 0.99; 95% CI, 0.93 to 1.05; low certainty). Subgroup analysis indicated possible reduced 90-day mortality in less severely ill patients (RR, 0.89; 95% CI, 0.80 to 0.98) but increased mortality in more severely ill patients (RR, 1.08; 95% CI, 0.96 to 1.20).
![](https://static.wixstatic.com/media/e4917c_30091d55945943b587d9ddaee1455652~mv2.jpg/v1/fill/w_147,h_74,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/e4917c_30091d55945943b587d9ddaee1455652~mv2.jpg)